Selective T cell receptor Vβ gene usage by alloreactive T cells responding to defined HLA-DR alleles

Transplantation

Volumn 62, Issue 9, 1996, Pages 1332-1340

  Lobashevsky, Andrew ^a   Kotb, Malak ^a   Gaber, A O ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA DR ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; T LYMPHOCYTE RECEPTOR;

ALLELE; ALLOIMMUNITY; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; ARTICLE; GENETIC ANALYSIS; GRAFT SURVIVAL; HLA SYSTEM; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; MAJOR HISTOCOMPATIBILITY COMPLEX; MIXED LYMPHOCYTE REACTION; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION;

ALLELES; ANTIGEN PRESENTATION; CELL LINE; GENE EXPRESSION REGULATION; GENES, IMMUNOGLOBULIN; HLA-DR ANTIGENS; HUMANS; IMMUNOGLOBULIN VARIABLE REGION; LYMPHOCYTE ACTIVATION; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; T-LYMPHOCYTES;

EID: 0030449557     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199611150-00027     Document Type: Article

References (53)

1. Sell S. Delayed hypersensitivity reactions (cell-mediated immunity). In: Immunopathology and immunity. New York: Elseveir Science, 1987: 471.
2. Warrens AN, Lombardi G, Lechler RI. Pesentation and recognition of alloantigens. In: Thomson AW, Catto GRD, eds. Immunology of renal transplantation. Boston: Hodder & Stoughton, 1993: 27.
3. Bushell A, Higgins RM, Wood KJ, Morris PJ. HLA-DQ mismatches between donor and recipient in the presence of HLA-DR compatibility do not influence the function of outcome of renal transplant. Hum Immunol 1989; 26: 179.
4. Opelz G, Mytilineos J, Scherer S, et al. Survival of DNA HLA-DR typed and matched cadaveric kidney transplants: The Collaborative Transplant Study. Lancet 1991; 338: 461.
5. Class F, Schreuder I, Persijn G, van Rood J. HLA and ABO matching in clinical renal transplantation. In: Thomson AW, Catto GRD, eds. Immunology of renal transplantation. Boston: Hodder & Stoughton, 1993: 177.
6. Matis LA, Sorger SB, McElligott DL, Fink PJ, Hedrick SM. The molecular basis of alloreactivity in antigen-specific, major histocompatibility complex-restricted T cell clones. Cell 1987; 51: 59.
7. de Koster HS, Anderson DC, Termijtelen A. T sensitized to synthetic HLA-DR3 peptide give evidence of continuous presentation of denatured HLA-DR3 molecules by HLA-DP. J Exp Med 1989; 169: 1191.
8. Lechler RI, Lombardi G, Batchelor JR, Reinsmoen N, Bach FH. The molecular basis of autoreactivity. Immunol Today 1990; 11: 83.
9. Eckels DD. Alloreactivity: allogeneic presentation of endogenous peptide or direct recognition of MHC polymorphism? Tissue Antigens 1990; 35: 49.
10. Liu Z, Braunstein NS, Suciu-Foca N. T cell recognition of allopeptides in context of syngeneic MHC. J Immunol 1992; 148: 35.
11. Liu Z, Sun Y-K, Xi Y-P, et al. Contribution of direct and indirect recognition pathways to T cell alloreactivity. J Exp Med 1993; 177: 1643.
12. Shoskes DA, Wood KJ. Indirect presentation of MHC antigens in transplantation. Immunol Today 1994; 15: 32.
13. Sayegh MH, Watschinger B, Carpenter CB. Mechanisms of T cell recognition of alloantigen: the role of peptides. Transplantation 1994; 57: 1295.
14. Chicz RM, Urban RG, Gorga JC, et al. Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles. J Exp Med 1993; 178: 27.
15. Creswell P. Assembly, transport and function of MHC class II molecules. Annu Rev Immunol 1994; 12: 259.
16. Miceli MC, Finn OJ. T cell receptor β-chain selection in human allograft rejection. J Immunol 1989; 142: 81.
17. Weyand C, Hicok KC, Goronzy JJ. Nonrandom selection of T cell specificities in anti-HLA-DR responses. J Immunol 1991; 147: 70.
18. Geiger MJ, Gorski J, Eckels DD. T cell receptor gene segment utilization by HLA-DR1-alloreactive T cell clones. J Immunol 1991; 147: 2082.
19. Goronzy JJ, Oppitz U, Weyand CM. Clonal heterogeneity of superantigen reactivity in human Vβ 6+ T cell clones: limited contributions of Vβ sequence polymorphisms. J Immunol 1992; 148: 604.
20. Hand SL, Hall BL, Finn OJ. T cell receptor Vβ gene usage in HLA-DR1-reactive human T cell populations: the predominance of Vβ 8. Transplantation 1992; 54: 357.
21. Yamanaka K, Kwok WW, Mickelson EM, et al. Selective T-cell-receptor gene usage in allorecognition and graft-versus-host disease. Transplantation 1993; 55: 1167.
22. Hurley KC, Steiner N, Wagner A, et al. Nonrandom T cell receptor usage in the allorecognition of HLA-DR1 microvariation. J Immunol 1993; 150: 1314.
23. Datema G, Vaessen LMB, Daane CR, et al. T-cell receptor V gene segment usage of graft-infiltrating T-lymphocytes after heart transplantation. Transplant Proc 1993; 25: 77.
24. Liu Z, Sun YK, Hong B, et al. Limited usage of T cell receptor Vβ genes by allopeptide-specific T cells. J Immunol 1993; 150: 3180.
25. Fink PJ, Matis LA, McElligott DL, Bookman M, Hedrick SM. Correlations between T-cell specificity and the structure of the antigen receptor. Nature 1986; 321: 219.
26. Beall SS, Lawrence JV, Bradley DA, et al. β-chain gene rearrangements and Vβ gene usage in DPw2-specific T cells. J Immunol 1987; 139: 1320.
27. Loveridge JA, Rosenberg WM, Kirkwood TB, Bell JI. The genetic contribution to human T-cell receptor repertoire. Immunology 1991; 74: 246.
28. Malhotra U, Spielman R, Concannon P. Variability in T cell receptor Vβ gene usage in human peripheral blood lymphocytes: studies of identical twins, siblings, and insulin-dependent diabetes mellitus patients. J Immunol 1992; 149: 1802.
29. Hawes GE, Struyk L, van den Elsen PJ. Differential usage of T cell receptor V gene segments in CD4+ and CD8+ subsets of T lymphocytes in monozygotic twins. J Immunol 1993; 150: 2033.
30. Akolkar PN, Gulwani-Akolkar B, Pergolizzi R, Bigler RD, Silver J. Influence of HLA genes on T cell receptor V segment frequencies and expression levels in peripheral blood lymphocytes. J Immunol 1993; 150: 2761.
31. Shimizu Y, De MR. Production of human cells expressing individual transferred HLA-A,-B,-C genes using an HLA-A,-B,-C null human cell line. J Immunol 1989; 142: 3320.
32. Nielsen B, Madsen PS, Jensen AW, Hokland P, Hokland M. Interferon-α-induced changes in surface antigens in a hairy-cell leukemia (JOK-1), and a Burkitt's lymphoma cell line (Daudi) during in vitro culture. Eur J Haematol 1992; 48: 146.
33. Kotb M, Watanabe-Ohnishi R, Wang B, et al. Analysis of the TCR Vβ specificities of bacterial superantigens using PCR. Immunomethods 1993; 2: 33.
34. Vignali D, Moreno J, Schiller D, Hammerling GJ. Species-specific binding of CD4 to the β2 domain of major histocompatibility complex class II molecules. J Exp Med 1992; 175: 925.
35. Olerup O, Zetterquist H. HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens 1992; 39: 225.
36. Choi Y, Kotzin B, Herron L, et al. Interaction of Staphylococcus aureus toxin "superantigens" with human T cells. Proc Natl Acad Sci USA 1989; 86: 8941.
37. Tomai MA, Aelion JA, Dockter ME, et al. T cell receptor V gene usage by human T cells stimulated with the superantigen streptococcal M protein. J Exp Med 1991; 174: 285.
38. Oksenberg JR, Stuart S, Begovich AB, et al. Limited heterogeneity of rearranged T-cell receptor V alpha transcripts in brains of multiple sclerosis patients. Nature 1991; 345: 344.
39. Tomai M, Kotb M, Majumdar G, Beachey EH. Superantigenicity of streptococcal M protein. J Exp Med 1990; 172: 359.
40. Chen RF, Maeda H. Functional roles of human class II antigens in T cell proliferative response: comparison of the DR and DQ molecules using mouse monoclonal antibodies. J Immunogenet 1986; 13: 401.
41. Borst J, De Vries E, Spits H, et al. Complexity of T cell receptor recognition sites for defined alloantigens. J Immunol 1987; 139: 1952.
42. Bragado R, Lauzurica P, Lopez D, Lopez de Castro JA. T cell receptor Vβ gene usage in human alloreactive response. J Exp Med 1990; 171: 1189.
43. Marrack P, Kappler J. The staphylococcal enterotoxins and their relatives. Science 1990; 248: 705.
44. Chien YH, Davis MM. How αβ T-cell receptors "see" peptide/ MHC complexes. Immunol Today 1993; 14: 597.
45. Goronzy JJ, Xie C, Hu W, Lundy SK, Weyand CM. Restrictions in the repertoire of allospecific T cells: contribution of the α-helical sequence polymorphism of HLA-DR molecules. J Immunol 1993; 151: 825.
46. Wilson KE, Ball E, Stasny P, Capra JD. Allorecognition of HLA DR2 and DR5 molecules by V-beta-8-positive T-cell clones. Scand J Immunol 1991; 33: 131.
47. Patten PA, Rock EP, Sonoda T, et al. Transfer of putative complementarity-determining region loops of T cell receptor V domains confers toxin reactivity but not peptide/MHC specificity. J Immunol 1993; 150: 2281.
48. Masewicz S, Ledbetter JA, Martin P, et al. Inhibition of allostimulated HLA-DQ and DP-specific T cells by staphylococcal enterotoxin A. Hum Immunol 1993; 36: 142.
49. Bellio M, Lone YC, de la Calle Martin O, et al. The Vβ complementarity determining region 1 of a major histocompatibility complex (MHC) class I-restricted T cell receptor is involved in the recognition of peptide/MHC I and superantigen/MHC II complex. J Exp Med 1994; 179: 1087.
50. Weining H, Cornelia M, Weyand C, Goronzy JJ. The T-cell receptor Vβ6 gene usage in alloreactive T-cell-responses. Hum Immunol 1995; 42: 72.
51. Hall BL, Finn OJ. T cell receptor Vβ gene usage in allograft-derived cell lines analyzed by a polymerase chain reaction technique. Transplantation 1992; 53: 1088.
52. Fung JJ, Thomson AW, Pinna A, Selby RR, Starzl TE. State of immunosuppressive agents in organ transplantation. Transplant Proc 1992; 24: 2372.
53. Bluestone JA, Bruce D, Peterson L, et al. Immunosuppressive effects of anti-CD3 MAb and soluble co-stimulatory molecules. Transplant Proc 1993.